RXST Q3'26 Earnings: EPS estimate is (0.31) USD

What happened

RxSight is scheduled to announce its Q3'26 results on November 3 after the market closes, with disclosure expected at 4:00 p.m. ET. The article gives estimated revenue of 27.19 million USD and estimated earnings per share, or profit or loss per share, of (0.31) USD.

Confirmed

Global impact / market context

The estimates provide a benchmark for judging RxSight’s report. Revenue below the forecast or a larger per-share loss could weaken expectations about sales and progress toward profitability; stronger figures could support them. Actual results may also shape investor positioning in the company’s shares.

Analyst inference

The supplied table shows estimates alongside previously reported quarters, but Q3'26 figures are still forecasts. Investors can compare the coming report with those expectations; any gap between forecast and actual sales or loss per share may change views of RxSight’s operating performance.

Analyst inference

What to watch

1. Compare reported Q3'26 revenue with the 27.19 million USD estimate. A shortfall would indicate sales were weaker than forecast, while a higher result would indicate stronger sales. Analyst inference
2. Review earnings per share against the forecast loss, which means the estimated loss allocated to each share. A larger loss could raise questions about profitability, though no cost breakdown is provided. Analyst inference
3. The article schedules the announcement for November 3 after market close, expected at 4:00 p.m. ET. Check the release and compare its reported results with the estimates. Confirmed

Evidence

• Original source link unavailable